These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 2064124

  • 1. The role of platelet-activating factor in the pulmonary response to inhaled bacterial endotoxin.
    Lantz RC, Keller GE, Burrell R.
    Am Rev Respir Dis; 1991 Jul; 144(1):167-72. PubMed ID: 2064124
    [Abstract] [Full Text] [Related]

  • 2. Mediators of pulmonary injury induced by inhalation of bacterial endotoxin.
    Burrell R, Lantz RC, Hinton DE.
    Am Rev Respir Dis; 1988 Jan; 137(1):100-5. PubMed ID: 3276251
    [Abstract] [Full Text] [Related]

  • 3. Modulation of pulmonary inflammation after endotoxin inhalation with a platelet-activating factor antagonist (48740 RP).
    Rylander R, Beijer L, Lantz RC, Burrell R, Sedivy P.
    Int Arch Allergy Appl Immunol; 1988 Jan; 86(3):303-7. PubMed ID: 3403044
    [Abstract] [Full Text] [Related]

  • 4. Morphometric changes of the lung induced by inhaled bacterial endotoxin.
    Lantz RC, Birch K, Hinton DE, Burrell R.
    Exp Mol Pathol; 1985 Dec; 43(3):305-20. PubMed ID: 4065310
    [Abstract] [Full Text] [Related]

  • 5. Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury.
    Salzer WL, McCall CE.
    J Clin Invest; 1990 Apr; 85(4):1135-43. PubMed ID: 2318970
    [Abstract] [Full Text] [Related]

  • 6. Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary report.
    Mojarad M, Hamasaki Y, Said SI.
    Bull Eur Physiopathol Respir; 1983 Apr; 19(3):253-6. PubMed ID: 6882949
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Release of platelet activating factor in rabbits with antibody-mediated injury of the lung: the role of leukocytes and of pulmonary endothelial cells.
    Camussi G, Pawlowski I, Bussolino F, Caldwell PR, Brentjens J, Andres G.
    J Immunol; 1983 Oct; 131(4):1802-7. PubMed ID: 6311899
    [Abstract] [Full Text] [Related]

  • 9. Evidence that platelet activating factor may mediate some acute inflammatory responses. Studies with the platelet-activating factor antagonist, CV3988.
    Issekutz AC, Szpejda M.
    Lab Invest; 1986 Mar; 54(3):275-81. PubMed ID: 3951199
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF release.
    Floch A, Bousseau A, Hetier E, Floc'h F, Bost PE, Cavero I.
    J Lipid Mediat; 1989 Mar; 1(6):349-60. PubMed ID: 2519903
    [Abstract] [Full Text] [Related]

  • 12. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC, Carter MB, Matheson PJ, Wills-Frank LA, Wilson MA, Wead WB, Garrison RN.
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [Abstract] [Full Text] [Related]

  • 13. Platelet-activating factor plays a pivotal role in the induction of experimental lung injury.
    Miotla JM, Jeffery PK, Hellewell PG.
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):197-204. PubMed ID: 9476906
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of endotoxin-induced microvascular leakage by a platelet-activating factor antagonist and 5-lipoxygenase inhibitor.
    Klabunde RE, Calvello C.
    Shock; 1995 Nov; 4(5):368-72. PubMed ID: 8595525
    [Abstract] [Full Text] [Related]

  • 15. [Participation of platelet activating factor in the pulmonary injury during cardiopulmonary bypass].
    Inui K.
    Nihon Kyobu Geka Gakkai Zasshi; 1993 Feb; 41(2):238-46. PubMed ID: 8473789
    [Abstract] [Full Text] [Related]

  • 16. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B, van der Poll T, Levi M, van Deventer SJ, ten Cate H, Imai Y, Hack CE, ten Cate JW.
    J Immunol; 1994 Mar 01; 152(5):2438-46. PubMed ID: 8133055
    [Abstract] [Full Text] [Related]

  • 17. The platelet activating factor receptor antagonist, RP 59227, blocks platelet activating factor receptors mediating liberation of reactive oxygen species in guinea pig macrophages and human polymorphonuclear leukocytes.
    Floch A, Tahraoui L, Sedivy P, Cavero I.
    J Pharmacol Exp Ther; 1991 Aug 01; 258(2):567-75. PubMed ID: 1650834
    [Abstract] [Full Text] [Related]

  • 18. Effect of the platelet activating factor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride on endotoxin-induced hypotension and hematological parameters in rats.
    Natsume Y, Imanishi N, Koike H, Morooka S.
    Arzneimittelforschung; 1994 Nov 01; 44(11):1208-13. PubMed ID: 7848333
    [Abstract] [Full Text] [Related]

  • 19. Pentoxifylline attenuates platelet activating factor-induced permeable edema in isolated perfused guinea pig lungs.
    Li SH, Fei X, Chen SF, Ding ZQ, Wu ZL.
    Zhongguo Yao Li Xue Bao; 1994 May 01; 15(3):219-22. PubMed ID: 7976374
    [Abstract] [Full Text] [Related]

  • 20. Effect of platelet-activating factor-receptor antagonism on endotoxin-induced lung dysfunction in sheep.
    Snapper JR, Lu W, Lefferts PL, Thabes JS.
    J Appl Physiol (1985); 1998 May 01; 84(5):1610-4. PubMed ID: 9572806
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.